Category Archives: Public Policy

Latest From Public Policy

Indiana Governor Signs Bill that Supports Transparent Communication

admin-ajax copy

Indiana Governor Mike Pence has signed bipartisan legislation enabling retail pharmacies within his state to substitute interchangeable biologic medicines, once approved, for the innovator drug on which they are based. Not only does this legislation empower pharmacists to use their professional discretion to automatically substitute interchangeable biologic medicines, it also ensures transparent communication within a patient’s entire health care team to ensure the best decisions possible. The newly signed Senate Bill 262 ensures pharmacists communicate with the Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Corporate-Sponsored University Research Valuable for Further Innovation

SBIR Reauthorization Moves Forward

New research published in Nature, Technology Transfer: Industry-funded academic inventions boost innovation, provides data undermining “assumptions that corporate-funded academic research is less accessible and useful to others.” After reviewing empirical evidence covering 20 years of inventions in the University of California system the authors find that: “Corporate-sponsored research is surprisingly valuable for further innovation. Data collected over 20 years at nine campuses and three national laboratories administered by the University of California show that corporate-sponsored Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Gene Patent Questions Remain: USPTO Issues Examiner Guidelines

Supreme Court

The new Patent Office guidance, issued March 4, extends the Supreme Court’s legal logic into areas that were neither mentioned nor decided in the Myriad case itself. Myriad went to the Supreme Court exclusively on the question whether human genes are patentable. And human genetic diagnostic testing was the only context in which the Supreme Court thought about this question. The Supreme Court also acknowledged that it is not a scientific expert, and perhaps recognized Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

PA Bio Names State Official of the Year

admin-ajax (1)

Pennsylvania State Representative Warren Kampf was selected as the recipient Pennsylvania Bio’s 2013 State Official of the Year Award. Representative Kampf will be honored at Pennsylvania Bio’s Annual Dinner and Awards Celebration on March 12th at the Pennsylvania Convention Center in Philadelphia.  The State Official of the Year recognizes a public official from the Commonwealth of Pennsylvania who has distinguished him/herself as a leader in the bioscience industry. The honoree is selected by the Pennsylvania Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Special 301: BIO Highlights Challenges in India

cells115x76

BIO recently testified before the U.S. government on the intellectual property challenges our members face in various markets around the world. Among other matters, BIO recommended that the U.S. government designate India as a Priority Foreign Country, a designation that would lead to the consideration of trade sanctions for treaty violations. Specifically, BIO testified: “In the healthcare space, only a few dozen innovative and patent protected medicines are on the market in India. Yet, in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,